UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): ~~January~~ 18May 9, 2019

SLEEPAID HOLDING CO.

(Exact Name of Registrant as Specified in its Charter)

Nevada

000-55446

47-3785730

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

Rm 10 1/F Wellborne Commercial Centre ~~8 Java Road North Point, Hong Kong (Address of Principal Executive Office) (Zip Code)~~

8 Java Road

North Point, Hong Kong

(Address of Principal Executive Office) (Zip Code)

Registrant's telephone number, including area code: (852) 2806-2312

~~____________________________________________~~_______________________________________________________

(former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

o¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item~~ITEM 15.0102. ~~Entry~~Departure ~~into~~of aDirectors ~~Material~~or ~~Definitive~~Principal ~~Agreement~~Officers; Election of Directors; Appointment of Principal Officers

On ~~January~~May 189, 2019, ~~a subsidiary of~~ Sleepaid Holding ~~Co. (the “~~Company~~”) entered into a Shares Trading Agreement (the “Agreement”) whereby the subsidiary~~, ~~Yugosu Investment Limited (“Yugosu”), agreed to sell its two subsidiaries, Guangzhou Sleepaid Household Supplies Co~~Inc., ~~Ltd.~~ (~~“Household”)~~the ~~and Guangzhou Yuewin Trading Co., Ltd. (~~“~~Yuewin~~Company”) toappointed ~~two~~Lowell ~~unrelated~~Howell ~~third~~as parties, Baitao Wang (“Wang”) and Guangzhou Pulosi Investment Consulting Co., Ltd. (“GPICC”). GPICC acquired 99% of Household and Yuewin and Wang acquired one percent (1%) of Household and Yuewin. As a ~~result~~director of ~~this Agreement,~~ the Company ~~no longer owns its subsidiaries, Household and Yuewin~~. ~~Yugosu received total consideration of 10,000 RMB.~~

OnMr. ~~January~~Holden 31has owned and operated his own consulting firm, ~~2019~~LS Enterprises, ~~the~~Inc., ~~Agreement~~which ~~was~~provides ~~completed~~business consulting, accounting and ~~ownership~~other ~~transferred~~services to businesses, since 1983. Mr. Holden has a broad range of business experience including managing, securing financing, structuring of transactions, and is experienced and knowledgeable in managing relationships with customers, financing institutions and stockholders. Presently Mr. Holden serves as the ~~new~~director ~~owners~~and Chief Financial officer of Nascent Biotech Inc. (“NBIO”), Chief Financial Officer of Skkynet Cloud Systems, Inc. (“SKKY”), Chief Financial Officer and director of EMR Technology, and Chief Executive Officer and director of PTS, Inc. (“PTSH”). Mr. Holden also has a background in assisting companies in fulfilling their financial auditing and SEC reporting requirements. Mr. Lowell Holden has a Bachelor of Science degree from Iowa State University.

~~Item~~ 2~~.01. Completion of Acquisition or Disposition of Assets~~

~~The information provided in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference~~SIGNATURES

~~Item~~Pursuant ~~9.01.~~to ~~Financial~~the ~~Statements~~requirements of the Securities and ~~Exhibits~~Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

(d) Exhibits

	SLEEPAID HOLDING CO.

Date: May 23, 2019	By:	/s/ Tao Wang
		Tao Wang, CEO

Exhibit Number		Exhibit Description
10.1		Shares Trading Agreement

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

	SLEEPAID HOLDING CO.
Date: April 19, 2019	By:	/s/ Tao Wang
		Tao Wang, CEO

Filing Compare · Sleepaid Holding Co.